Deliver eConsent to sites and study participants around the globe with confidence
More than just the latest electronic consent software, IQVIA Complete Consent combines a friendly, feature-rich technology platform that patients and sites are eager to use, with the powerful, scalable, operational infrastructure that sponsors need to make global implementations successful.
Move to Decentralized and Hybrid Trials at Warp Speed
IQVIA Technologies’ eConsent solution is a proven component in large-scale, direct-to-patient clinical trials that delivered new treatments and vaccines to patients and populations in record time.
- Unmatched ability to scale, with more patient consents completed in 2020/21 than accomplished by the entire industry in all previous years
- Proven in nearly 30 COVID-19 studies and counting, including 10 major vaccine trials, most with tens of thousands of patients enrolled within months
- More than 100,000 patient informed consents completed at nearly 10,000 sites across 35 countries in 60 languages within virtual trial settings
To ask questions or provide feedback about this brochure, please use the Request Info button below. Be sure to indicate if you’d like to schedule a follow-up discussion or demo.